MedPath
NMPA Approval

Levosalbutamol Hydrochloride Nebuliser Solution

国药准字H20233263

March 7, 2023

Drug Information

盐酸左沙丁胺醇雾化吸入溶液

吸入制剂

3ml:0.31mg(按C₁₃H₂₁NO₃计)

化学药品

March 7, 2023

Company Information

Applicant Company

江西省南昌市南昌高新技术产业开发区瑶湖北大道3333号济民可信总部及新药产业化基地项目(一期)质检楼1层

Manufacturing Company

江西省南昌市南昌高新技术产业开发区瑶湖北大道3333号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸左沙丁胺醇雾化吸入溶液 - NMPA 批准文号 | MedPath